Associated Papers
Age-associated mortality is partially mediated by TERT promoter mutation status in differentiated thyroid carcinoma.
Heo J et al.
Plos One, 2023
Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients.
Song YS et al.
Cancer, 2016
TERT promoter mutations in renal cell carcinomas and upper tract urothelial carcinomas.
Wang K et al.
Oncotarget, 2014
Select a paper to view details